BlackRock Health Sciences Term Trust (NYSE:BMEZ) to Issue Monthly Dividend of $0.11

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Friday, June 5th. Stockholders of record on Friday, August 14th will be paid a dividend of 0.11 per share on Monday, August 31st. This represents a c) annualized dividend and a dividend yield of 8.2%. The ex-dividend date of this dividend is Friday, August 14th.

BlackRock Health Sciences Term Trust Trading Up 0.0%

NYSE BMEZ opened at $16.12 on Wednesday. The firm’s 50 day moving average price is $15.16 and its 200-day moving average price is $14.75. BlackRock Health Sciences Term Trust has a 52-week low of $13.70 and a 52-week high of $16.20.

Institutional Trading of BlackRock Health Sciences Term Trust

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Rivernorth Capital Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 24.8% in the 1st quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock valued at $11,620,000 after acquiring an additional 160,629 shares during the period. Saba Capital Management L.P. purchased a new stake in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth $10,907,000. Lazard Asset Management LLC lifted its stake in shares of BlackRock Health Sciences Term Trust by 64.2% during the 1st quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock worth $8,926,000 after purchasing an additional 243,054 shares during the last quarter. Quantedge Capital Pte Ltd boosted its position in BlackRock Health Sciences Term Trust by 85.0% during the first quarter. Quantedge Capital Pte Ltd now owns 135,854 shares of the company’s stock valued at $1,951,000 after purchasing an additional 62,400 shares in the last quarter. Finally, PNC Financial Services Group Inc. bought a new stake in BlackRock Health Sciences Term Trust during the first quarter valued at about $35,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.